cGMP-elevating agents suppress proliferation of vascular smooth muscle cells by inhibiting the activation of epidermal growth factor signaling pathway

Circulation

Volumn 95, Issue 5, 1997, Pages 1269-1277

  Yu, Sheu Meei ^a   Hung, Li Man ^a   Lin, Chia Chih ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

atherosclerosis; drugs; muscle, smooth; protein kinase; signal transduction

Indexed keywords

1 BENZYL 3 (5' HYDROXYMETHYL 2' FURYL)THIENO[3,2 C]PYRAZOLE; A 02131 1; CYCLIC GMP; EPIDERMAL GROWTH FACTOR; NITROPRUSSIDE SODIUM; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CELL PROLIFERATION; DRUG EFFECT; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; VASCULAR SMOOTH MUSCLE;

EID: 0031035398     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.95.5.1269     Document Type: Article

References (10)

1. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801-809.
2. Garg UC, Hassid A. Nitric oxide-generating vasodilators and 8-bromocyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest. 1989;83:1774-1777.
3. Moncada S, Palmer RMJ, Higgs EA. NO: physiology, pathophysiology and pharmacology. Pharmacol Rev. 1991;43:109-142.
4. Garg UC, Hassid A. Mechanisms of nitrosothiol-induced antimitogenesis in aortic smooth muscle cells. Eur J Pharmacol. 1993;237:243-249.
5. Dubey RK. Vasodilator derived nitric oxide inhibits angiotensin II-and fetal calf serum-induced growth of renal arteriolar smooth muscle cells. J Pharmacol Exp Ther. 1994;269:402-403.
6. Beavo JA, Reifsnyder DH. Primary sequence of cyclic nucleotide phosphodiesterase isoenzymes and the design of selective inhibitors. Trends Pharmacol Sci. 1990;11:150-155.
7. Macphee CH, Harrison SA, Beavo JA. Immunological identification of the major platelet low-km cAMP phosphodiesterase: probable target for antithrombotic agents. Proc Natl Acad Sci USA. 1986;83:6660-6668.
8. Yu SM, Tsai SY, Kuo SC, Ou JT. Inhibition of platelet function by A02131-1: a novel inhibitor of cGMP-specific phosphodiesterase, in vitro and in vivo. Blood. 1996;87:3758-3767.
9. Shahid M, van Amsterdam ROM, de Boer J, Berge RE, Nicholson CD, Zaagsma J. The presence of five cyclic nucleotide phosphodiesterase isoenzyme activities in bovine tracheal smooth muscle and the functional effects of selective inhibitors. Br J Pharmacol. 1991;104:471-477.
10. Yu SM, Cheng ZJ, Kuo SC. Endothelium-dependent relaxation of rat aorta by butein, a novel cyclic AMP-specific phosphodiesterase inhibitor. Eur J Pharmacol. 1995;280:69-77.